Double stranded RNA-dependent protein kinase is involved in osteoclast differentiation of RAW264.7 cells in vitro

Junpei Teramachi1, Hiroyuki Morimoto, Ryoko Baba

  • 1Department of Histology and Oral Histology, Institute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto, Tokushima 770-8504, Japan.

Insights

Double-stranded RNA-dependent protein kinase (PKR) is essential for osteoclast differentiation. Inhibiting PKR or using a PKR mutant blocked the formation of these bone-resorbing cells, revealing a key role in bone biology.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Bone Biology

Background:

  • Double-stranded RNA-dependent protein kinase (PKR) is a crucial mediator of cellular stress responses and has known roles in host defense and cell proliferation.
  • Previous research established PKR's involvement in osteoblast differentiation and calcification.
  • The specific role of PKR in osteoclast differentiation remained largely uncharacterized.

Purpose of the Study:

  • To investigate the function of PKR in the differentiation process of osteoclasts.
  • To determine if PKR signaling is necessary for the formation of functional osteoclasts.

Main Methods:

  • Established a stable RAW264.7 cell line expressing a dominant-negative PKR mutant (PKR-K/R).
  • Utilized RANKL stimulation to induce osteoclast differentiation in wild-type and PKR-K/R cells.
  • Employed RT-PCR and Western blotting to analyze gene and protein expression of osteoclast markers and signaling pathways.
  • Administered a specific PKR inhibitor (2-aminopurine) to assess its impact on osteoclastogenesis.
  • Performed immunohistochemical analysis on mouse bone tissue.

Main Results:

  • RAW264.7 cells expressing the PKR mutant (PKR-K/R) failed to differentiate into TRAP-positive multinuclear osteoclasts upon RANKL stimulation.
  • A specific PKR inhibitor, 2-aminopurine, significantly suppressed RANKL-induced osteoclast differentiation.
  • Expression of key osteoclast markers (cathepsin K, calcitonin receptor) and fusion-related genes was downregulated in PKR-deficient cells.
  • NF-κB signaling was suppressed, while STAT1 expression was elevated in PKR-K/R cells.
  • PKR was confirmed to be localized in mature osteoclasts in mouse bone tissue.

Conclusions:

  • PKR plays a critical and indispensable role in osteoclast differentiation and function.
  • PKR signaling is essential for the expression of osteoclast-specific genes and the activation of key regulatory pathways like NF-κB.
  • Targeting PKR may offer a novel therapeutic strategy for modulating bone resorption in diseases characterized by excessive osteoclast activity.